This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Novartis Ag. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Basel, CH (2001)
- Uckfield, GB (2002)
Company Filing History:
Years Active: 2001-2002
Title: Gillian Rosemary Bullock: Innovator in Pharmaceutical Preparations
Introduction
Gillian Rosemary Bullock is a notable inventor based in Uckfield, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic uses for AT receptor antagonists and modulators. With a total of 2 patents, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Gillian's latest patents include innovative approaches to utilizing AT receptor antagonists. The first patent focuses on the additional therapeutic use of these antagonists for producing pharmaceutical preparations aimed at treating conditions associated with increased AT receptors in the sub-epithelial area or epithelia. The second patent addresses the stimulation of apoptosis through the use of an AT receptor antagonist, providing a pharmaceutical preparation that can help in treating pathological symptoms that are significantly reduced, halted, or prevented by apoptosis.
Career Highlights
Throughout her career, Gillian has worked with prominent companies in the pharmaceutical industry, including Novartis AG. Her expertise and innovative mindset have allowed her to contribute to advancements in medical treatments and therapies.
Collaborations
Gillian has collaborated with esteemed professionals in her field, including Marc De Gasparo and Sabina Maria Ganter. These collaborations have further enriched her research and development efforts.
Conclusion
Gillian Rosemary Bullock stands out as an influential inventor in the pharmaceutical sector, with her patents paving the way for new therapeutic options. Her dedication to innovation continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
